References
- Spilker B. Quality of Life Assessment in Clinical Trial.New York, NY: Raven,1990.
- Lee S Y, Lee H J, Kim Y K, , et al. Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients.J Psychosom Res. 2004;57(1):5–10. [PUBMED], [INFOTRIEVE], [CSA]
- Lew S Q, Piraino B. Quality of life and psychological issues in peritoneal dialysis patients.Semin Dial. 2005;18(2):119–123. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wuerth D, Finkelstein S H, Finkelstein F O. The identification and treatment of depression in patients maintained on dialysis.Semin Dial. 2005;18(2):142–146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kimmel P L, Peterson R A. Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs.Semin Dial. 2005;18(2):91–97. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation.Am J Kidney Dis. 1997;30:S15–S136. [CSA]
- Demirsoy A D. The MOS SF-36 Health Survey: a validation study with a Turkish Sample.In: Unpublished master's thesis.Istanbul: Department of Psychology, Bogaziçi University, 1999, [in Turkish].
- Yazıcı M K, Demir B, Tanrıverdi N, Karaağaoglu E, Yolaç P. Validity and inter-rater reliability of Hamilton Anxiety Rating Scale [Turkish].Turk Psikiyat Derg. 1998;9:114–117. [CSA]
- Beusterien K M, Nissenson A R, Port F K, Kelly M, Steinwald B, Ware J E Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients.J Am Soc Nephrol. 1996;7:763–773. [PUBMED], [INFOTRIEVE], [CSA]
- Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson B G. A randomized controlled trial of hemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.Nephrol Dial Transplant. 2003;18:353–361. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Koo J R, Yoon J W, Kim S G, , et al. Association of depression with malnutrition in chronic hemodialysis patients.Am J Kidney Dis. 2003;41(5):1037–1042. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Koo J R, Yoon J Y, Joo M H, , et al. Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients.Am J Med Sci. 2005;329(1):1–5. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lundin A P, Akerman M J, Chesler R M, , et al. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.Nephron. 1991;58:315–319. [PUBMED], [INFOTRIEVE], [CSA]
- Pascual J, Teruel J L, Moya J L, Liano F, Jimenez-Mena M, Ortuno J. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.Clin Nephrol. 1991;35:280–287. [PUBMED], [INFOTRIEVE], [CSA]
- Parfrey P S, Foley R N, Harnett J D, Kent G M, Murray D C, Barre P E. Outcome and risk factors for left ventricular disorders in chronic uraemia.Nephrol Dial Transplant. 1996;11:1277–1285. [PUBMED], [INFOTRIEVE], [CSA]
- Hayashi T, Suzuki A, Shoji T, , et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.Am J Kidney Dis. 2000;35:250–256. [PUBMED], [INFOTRIEVE], [CSA]
- Moreno F, Sanz-Guajardo D, Lopez-Gomez J M, Jofre R, Valderrabano F. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology.J Am Soc Nephrol. 2000;11:335–342. [PUBMED], [INFOTRIEVE], [CSA]
- Pickett J L, Theberge D C, Brown W S, Schweitzer S U, Nissenson A R. Normalizing hematocrit in dialysis patients improves brain function.Am J Kidney Dis. 1999;33:1122–1130. [PUBMED], [INFOTRIEVE], [CSA]
- Baumann H, Gauldie J. The acute phase response.Immunol Today 1994;25:74–80. [CSA], [CROSSREF]
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation.N Engl J Med. 1999;340:448–454. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Maes M, Song C, Lin A, , et al. Immune and clinical correlates of psychological stress-induced production of interferon-γ and interleukin-10 in humans. In: Plotnikoff N,Murgo A,Faith R,Good R, eds. Cytokines: Stress and Immunity.Boca Raton, FL: CRC Press, 1999:39–47.
- Miller G E, Stetler C A, Carney R M, Freedland K E, Banks W A. Clinical depression and inflammatory risk markers for coronary heart disease.Am J Cardiol. 2002;90:1279–1283. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ladwig K H, Marten-Mittag B, Lowel H, Doring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men.Brain Behav Immun. 2003;17(4):268–275. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ford D E, Erlinger T P. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey.Arch Intern Med. 2004;164(9):1010–1014. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hung C Y, Chen Y A, Chou C C, Yang C S. Nutritional and inflammatory markers in the prediction of mortality in Chinese hemodialysis patients.Nephron Clin Pract. 2005;100(1):c20–c26 [Epub ahead of print]. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]